PRPO

Precipio (PRPO)

About Precipio (PRPO)

Precipio, Inc.is a cancer diagnostics and reagent technology company, which provides diagnostic products and services to the oncology market. Its products include ICP, HemeScreen, and IV-Cell, and services include primary diagnostic, SmartPath, SmartGen, HemeScreen Panel, and ICE COLD-PCR. The company was founded on March 6, 1997 and is headquartered in New Haven, CT.

Details

Daily high

$23.75

Daily low

$22.12

Price at open

$23.35

52 Week High

$28.50

52 Week Low

$3.90

Market cap

38.9M

Dividend yield

0.00%

Volume

8,455

Avg. volume

10,346

P/E ratio

-26.58

Precipio News